ALK-POSITIVE LARGE B-CELL LYMPHOMA
Clinical trials for ALK-POSITIVE LARGE B-CELL LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new ALK-POSITIVE LARGE B-CELL LYMPHOMA trials appear
Sign up with your email to follow new studies for ALK-POSITIVE LARGE B-CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug cocktail aims to tame aggressive lymphoma
Disease control Recruiting nowThis early-stage study tests the safety of adding two targeted drugs (polatuzumab vedotin and possibly glofitamab) to standard chemotherapy for people with untreated, fast-growing B-cell lymphoma. About 56 participants will receive the combination to see if it is tolerable and ca…
Matched conditions: ALK-POSITIVE LARGE B-CELL LYMPHOMA
Phase: PHASE1 • Sponsor: University of Washington • Aim: Disease control
Last updated May 01, 2026 16:00 UTC
-
New drug SGR-1505 enters human testing for B-Cell cancers
Disease control Recruiting nowThis early-phase trial tests a new drug called SGR-1505 in adults with various B-cell blood cancers (like lymphoma and leukemia). The main goals are to find the safest dose and understand side effects. About 98 participants will receive the drug, and researchers will monitor how …
Matched conditions: ALK-POSITIVE LARGE B-CELL LYMPHOMA
Phase: PHASE1 • Sponsor: Schrödinger, Inc. • Aim: Disease control
Last updated Apr 29, 2026 15:02 UTC